Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
Primary Purpose
Esophageal Stricture
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
combination of local steroid injection(triamcinolone )with oral steroid administration(prednisone)
oral steroid administration(prednisone)
Sponsored by
About this trial
This is an interventional prevention trial for Esophageal Stricture focused on measuring esophageal stricture, endoscopic submucosal dissection, prevention
Eligibility Criteria
Inclusion Criteria:
- Patients who has undergone esophageal ESD
- Histologically confirmed early squamous cell carcinoma or high grade intraepithelial neoplasia of the esophagus
- ESD resulted in a mucosal defect involving more than two-thirds of the esophageal circumference.
Exclusion Criteria:
- Severe circulatory or respiratory disease,severe renal impairment
- Women in pregnancy and lactation
- Patients with steroid contraindications
- Patients refuse to join in this study
Sites / Locations
- Zhongshan Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
combination group
control group
Arm Description
combination of local steroid injection(triamcinolone )with oral steroid administration(prednisone)
oral steroid administration(prednisone)
Outcomes
Primary Outcome Measures
the stricture rate
the incidence of esophageal rate after ESD
the time when stricture occurs
Secondary Outcome Measures
the frequency of dilatation sessions required
the frequency of dilatation sessions required after stricture
the frequency of complications
complications related with steroid administrations or the process of ESD
Full Information
NCT ID
NCT03039608
First Posted
January 26, 2017
Last Updated
September 3, 2019
Sponsor
Shanghai Zhongshan Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03039608
Brief Title
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
Official Title
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm:a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
February 10, 2017 (Actual)
Primary Completion Date
July 10, 2018 (Actual)
Study Completion Date
November 10, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Zhongshan Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The method of esophageal endoscopic submucosal dissection (ESD) to remove superficial esophageal neoplasms has gained widespread acceptance as an alternative to surgery recently these years especially in Asian countries. However, besides of perforation and bleeding, another complication postoperative esophageal stricture is frequently observed after the removal of large-sized esophageal neoplasms by ESD. Dysphagia caused by postoperative stricture substantially decreases the patient's quality of life, requiring further therapy. Although the exact incidence is unknown, esophageal stricture is supposed to be related to the extent of the circumference being resected. In previous study by Ono et al,it is reported that 90% of patients with lesions of circumferential extension of more than three-fourths experienced postoperative stricture after esophageal ESD. There were some reported studies exploring new ways to prevent esophageal stricture after ESD, such as oral prednisolone and local corticosteroid injection. Corticosteroids can inhibit not only collagen synthesis but also enhance collagen breakdown, thereby inhibiting stricture formation. Some studies reveled that just oral prednisolone oral is effective option for the prevention of post-ESD stricture. However, most of the reported studies were non RCTs with small sample. In the primary study, the investigators search a new method of combination of both oral and local injection to prevent esophageal stricture,as a result,stricture at 8 weeks after ESD was found in 19 of 36 patients in the no corticosteroid group but only 4 of 34 in the corticosteroid group. Unfortunately,the study was also retrospective. So, the investigators plan to undertake a prospective, randomized controlled trial to evaluate the prophylactic effects of combination of local steroid injection with oral steroid administration for esophageal stenoses complicating extensive ESD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Stricture
Keywords
esophageal stricture, endoscopic submucosal dissection, prevention
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
72 (Actual)
8. Arms, Groups, and Interventions
Arm Title
combination group
Arm Type
Experimental
Arm Description
combination of local steroid injection(triamcinolone )with oral steroid administration(prednisone)
Arm Title
control group
Arm Type
Active Comparator
Arm Description
oral steroid administration(prednisone)
Intervention Type
Drug
Intervention Name(s)
combination of local steroid injection(triamcinolone )with oral steroid administration(prednisone)
Intervention Description
local steroid injection and oral steroid
Intervention Type
Drug
Intervention Name(s)
oral steroid administration(prednisone)
Intervention Description
oral steroid
Primary Outcome Measure Information:
Title
the stricture rate
Description
the incidence of esophageal rate after ESD
Time Frame
12weeks
Title
the time when stricture occurs
Time Frame
12weeks
Secondary Outcome Measure Information:
Title
the frequency of dilatation sessions required
Description
the frequency of dilatation sessions required after stricture
Time Frame
12 months
Title
the frequency of complications
Description
complications related with steroid administrations or the process of ESD
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who has undergone esophageal ESD
Histologically confirmed early squamous cell carcinoma or high grade intraepithelial neoplasia of the esophagus
ESD resulted in a mucosal defect involving more than two-thirds of the esophageal circumference.
Exclusion Criteria:
Severe circulatory or respiratory disease,severe renal impairment
Women in pregnancy and lactation
Patients with steroid contraindications
Patients refuse to join in this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meidong Xu, PhD
Organizational Affiliation
Shanghai Zhongshan Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhongshan Hospital
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China
12. IPD Sharing Statement
Learn more about this trial
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
We'll reach out to this number within 24 hrs